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What do those Epidermal T Cells do in Psoriasis?
Psoriasis is a complex inflammatory disease associated with polygenic skin, and analysing cytokine message in biopsies, have previously
suggested a TH1 (CD4) cytokine profile. Austin et al have directlyinheritance and characterized by a unique clustering of activated T
isolated T cells from psoriasis epidermis and demonstrated that thecells in the skin lesions. The presence of the activated T cells, however,
majority of both CD8 and CD4 intraepidermal T cells can produce ais the controlling feature of psoriasis because treatments that specifically
general T1 cytokine pattern within the lesional epidermis. Becausetarget activated T cells cause lesions to resolve. T lymphocytes are
IFN-γ has been shown to be key in inducing and maintaining theactivated through the specificity of their T cell receptors (TCR), and
epidermal proliferation and differentiation phenotype in psoriasis, thiscan show clonal activation in response to defined classical antigens
is strong evidence that these lymphocyte populations are critical inor restricted polyclonal activation (Vb subsets) to superantigens or
maintaining the psoriatic phenotype.unrestricted polyclonal activation to mitogens. Lymphocytes can also
This evidence argues against speculation that these cells are immunebe defined by the cytokines that they produce. The type I (T1)
suppressors, and it is also unlikely that these cells act as cytotoxiccytokine pattern of activated T cells (IFN-γ, TNF-α, 6IL-2, and little
effectors in the traditional sense, because there is little evidence ofIL-4) is associated with effector Type 1 cells such as in delayed type
overt keratinocyte apoptosis in psoriatic lesions. A recent study,hypersensitivity (DTH) responses. The type II (T2) pattern (IL-4,
however, shows that cytotoxic effectors can mediate their antiviralIL-10, and little IFN-γ) influences antibody response and can down-
effects with cytokines alone and it looks like this is true for psoriasis.regulate some Type I responses. Multiple approaches to elucidating the The relative scarcity of T cells that produce T2 cytokines in the
cause of psoriasis have suggested that lesions are associated with a Type epidermis when compared with T1 cytokines or overall in the blood
I cytokine expression pattern, and that activated skin lymphocytes are T cells, points to the potential for a general deficiency in T2 cytokine
oligoclonal or restricted polyclonal even early in the development of production in the lesion. This last speculation is supported by the
lesions. The intraepidermal T cells in psoriasis lesions, however, are intriguing observation that not only is there a strong T1 environment
largely activated CD8 T cells with a rather restricted TCR repertoire in the epidermis, but there is also a systemic shift towards T1 cytokine
(Vb expression) suggesting clonal T cells, and are believed to be production in circulating T cells. Psoriasis may no longer be a disease
important in the maintenance of psoriatic plaques. What activates these just of the skin, but may be the result of a centralized immunologic
cells and what is the function of these intraepidermal T cells? imbalance.
A paper in this issue by Austin et al (p. 752) demonstrates that the This paper also provides additional support to the concept that
epidermalal T cells in psoriasis have the ability to produce the T1 psoriasis is a lymphocyte-driven disease in which the overall Type I
cytokines IFN-γ, TNF-α, and IL-2. Previous studies using immuno- cytokine pattern in the skin directly induces the ‘‘regenerative epidermal
phenotype’’ characteristic of psoriasis.histochemistry of psoriasis lesions, isolating T cell clones for psoriatic
How Do Melanocytes Die?
synthesis in general in response to stress. They also identified the A2bPhenolic agents are a major cause of occupational vitiligo, or more
receptor (a P1 receptor for adenosine). Differential expression of thisproperly, occupational leukoderma. It has been proposed that pigment
gene was confirmed in an Rnase protection assay, by RT-PCR andcells can develop ‘‘autocytotoxicty’’ when exposed to toxic chemicals,
by flow cytometry.and the biochemistry of these events has been studied, especially with
Interestingly, in some cell types this receptor has been associatedregard to effects on melanization. There is not clear evidence, however,
with apoptosis induction, and the authors speculate that this may beon how toxic phenolic compounds induce cell death in human
the mechanism of 4-TBP cytotoxicity, which they feel is consistentmelanocytes.
with the morphologic changes seen.In this issue, Le Poole et al (p. 725) report utilization of a very
If 4-TBP does induce melanocyte apoptosis, the lack of inductiondifferent approach to directly compare genes that are differentially
of transcription of key apoptosis inducers and control proteins suggestsactivated or suppressed in melanocytes when the cells are exposed to
that in these cells, all of the proteins necessary for the apoptosis cascadea phenolic cytotoxic agent. They have used differential mRNA display
are preformed and ready to be activated. Alternatively, the lack ofto directly identify changes in mRNA expression in normal human
induction of specific proteins may indicate that 4-TBP produces suchmelanocytes exposed to 4-tertiary butyl phenol (4-TBP) compared
a profound toxic stress that these cells are unable to mount a robustwith untreated controls. They identified transcriptional activation of
the L30 ribosomal protein, possible reflecting altered levels of protein repair or stress response. Further studies will clarify this point.
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Control of Angiogenesis in the Skin Angiogenesis
Control of angiogenesis in the skin angiogenesis is the process of new Arbiser et al (p. 838) report a new angiogenic factor with rather
blood vessel formation in an already established vascular network. It is selective pattern of function. Corticotropin releasing hormone (CRH)
a key component in critical biologic functions such as wound healing is the major hypothalamic regulator of the endocrine pituitary-adrenal
and coronary artery revascularization following infarction, and promotes axis. CRH is also released peripherally, is a mediator of inflammation,
disease in tumor survival, vascular neogenesis of the cornea, and and is released by some tumors. Arbiser et al report that CRH acts as
diabetic neovasculaization. Angiogenesis is promoted by the interaction a chemotactic factor for endothelial cells, acting through the CRH
of multiple growth factors such as the multiple forms and isoform of receptor. In addition, a human epithelial tumor engineered to over-
VEGF, bFGF, PDGF, PKGF, angiopoietin 1, and matrix metallo- express CRH showed greatly enhanced angiogenesis and tumor growth
proteinases, and is opposed by a growing list of inhibitors such as when injected subcutaneously in a mouse animal model. Interestingly,
thrombospondin 1 and 2, angiostatin, and angiopoietin 2. Promotion CRH does not induce corneal neovascularization, suggesting a more
of wound healing and promotion of tumor survival are two important selective angiogenic effect. Just as other neurohormones such as theareas of cutaneous biology considered in two papers in this issue.
proopopiomelanocortins have important biologic effects in the skin,Kyriakides et al (p. 782) have examined the role of angiogenesis in
CRH may be one of a group of neurohormones that regulate importantwound healing by measuring skin wound healing in a thrombospondin-
systemic functions. The finding of CRH as an angiogenesis stimulator2 (Tsp-2) null mouse. Wounds in the TSP-2 null mice healed more
suggests that ectopic hormones secreted by cancers may serve torapidly and with less scarring than in the parent line. The granulation
enhance tumor angiogenesis.tissue appeared to be more cellular and better vascularized in the tsp-
Regulation of angiogenesis and associated key biologic functions in2 null mice, but epithelialization did not appear to be affected. It
animal models provides clues for future therapeutic directions toappears that TSP-2 may play an important role in controlling granulation
enhance wound healing and reduce scarring, to reverse tumor growth,tissue formation during healing, perhaps by controlling fibroblast–
matrix interactions. and to eliminate neovascularization, which interferes with function.
